SCHEMBL8110676

SCHEMBL8110676

CN(Cc1ccccc1)c1cnc2cc3cn[nH]c3cc2n1.c1ccc(COCc2cnc3cc4[nH]ncc4cc3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 5/20 0.39
▸ ROCK1 Q13464 4/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.38
▸ ERAP1 Q9NZ08 1/20 0.37
▸ RPS6KB1 P23443 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PTGER1 P34995 2/20 0.35
▸ SLC6A2 P23975 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ CDC7 O00311 3/20 0.33
▸ JAK2 O60674 2/20 0.33
▸ GSK3B P49841 2/20 0.33
▸ AURKB Q96GD4 2/20 0.33
▸ AURKA O14965 1/20 0.33
▸ CHUK O15111 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6619442 0.90 ROCK2 (0.46) ROCK2ROCK1ERAP1RPS6KB1SMN1; SMN2
SCHEMBL6617981 0.90 ROCK2 (0.46) ROCK2ROCK1ERAP1RPS6KB1SMN1; SMN2
SCHEMBL6616873 0.87 MKNK1 (0.43) ROCK2ROCK1MKNK1RPS6KB1TSHR
SCHEMBL6618548 0.87 MKNK1 (0.43) ROCK2ROCK1MKNK1RPS6KB1TSHR
SCHEMBL8117078 0.79 MKNK1 (0.38) ROCK2ROCK1MKNK1RPS6KB1SMN1; SMN2
SCHEMBL6618464 0.75 ROCK2 (0.49) ROCK2ROCK1MKNK1RPS6KB1CDC7
SCHEMBL6618856 0.75 ROCK2 (0.49) ROCK2ROCK1MKNK1RPS6KB1CDC7
SCHEMBL6616216 0.74 CYSLTR1 (0.46) SMN1; SMN2MAPTTSHRCDC7GSK3B
SCHEMBL6617440 0.74 ROCK2 (0.49) ROCK2ROCK1MKNK1RPS6KB1CDC7
SCHEMBL6617033 0.74 ROCK2 (0.49) ROCK2ROCK1MKNK1RPS6KB1CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-A4 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE POULENC RORER PHARMA (US) 2000-02-23 — — EP disclosed
EP-0779889-A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-06-25 — — EP disclosed
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 — — WO disclosed
Send feedback